The ASM math: what ±9% of Part B in 2027 means for your surgeons.

While everyone was digesting TEAM, CMS finalized a second mandatory model aimed one level down — not at the hospital, at the individual specialist. The Ambulatory Specialty Model (ASM) was finalized October 31, 2025, it is mandatory with no opt-out, and its first performance year begins January 1, 2027. One of its two launch cohorts is low back pain — which pulls orthopaedic surgeons, spine surgeons, neurosurgeons, and pain physicians into individual cost-and-quality scoring against their peers.

The number to sit with

ASM puts up to ±9% of a specialist’s Medicare Part B payments on the line, tied to how their cost and quality compare to peers. Run that against your own roster. A spine surgeon billing $600,000* in Part B professional fees sits inside an $108,000* annual swing — a −9% adjustment and a +9% adjustment are $54,000* apart from zero, in each direction, per surgeon, per year. Multiply by the number of scored physicians in your MSK service line and you have the size of the new P&L item that did not exist last year.

Why “versus peers” is the sharp edge

This is a tournament, not a threshold. Your surgeons aren’t scored against a fixed benchmark they can quietly clear; they’re scored against the distribution of their specialty. Somebody occupies the bottom of that curve by construction. The physicians who can show appropriate imaging, documented conservative care, tracked outcomes, and clean episode costs will take payment from the physicians who can’t — the same peer-curve logic we described for facilities, now applied to individual NPIs.

What a service-line leader does between now and January 2027

• Find out who’s in. Identify which of your physicians bill the low-back codes that drive cohort inclusion, in which regions. The exposure conversation is per-NPI, not per-department.
• Baseline the low-back pathway now. Imaging rates, injection sequences, PT-first adherence, time-to-surgery. The 2027 performance year is scored on what your physicians are already doing by then — the fixing has to happen in 2026.
• Instrument outcomes before CMS does. If the only cost-and-quality picture of your surgeons is the one CMS assembles from claims, you will meet your own service line for the first time inside a penalty letter. Surgeon-side outcome and billing instrumentation — the layer our sibling surgeonvalue.com exists for — is how a surgeon walks into the peer curve with their own evidence.
• Treat the non-surgical majority as scored work. Under ASM, the conservative-care patient is not a lost lead; they are part of the physician’s cost profile. Screened intake and structured non-operative pathways (the same demand-engine plumbing that feeds your OR) now defend the score too.
• Connect it to your episode work. The center already building TEAM discipline — personalized planning, tracked recovery, an instrumented 30-day window — is building the exact record that keeps its surgeons on the right half of the ASM curve. One system, two mandates.

The pattern across 2025–2027 is not subtle: episode accountability arrived for the hospital, then the ASC, and now the individual specialist, on a fixed calendar, without an opt-out box. The question is no longer whether your surgeons will be compared. It’s whether they’ll be compared using their data or someone else’s.

Figures marked * are illustrative and program-dependent; not clinical, legal, or financial advice. MSKvalue assembles independent best-of-class products with the American Joint Replacement Registry as the outcomes backbone.